Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChrysalis Inves Regulatory News (CHRY)

Share Price Information for Chrysalis Inves (CHRY)

Share Price is delayed by 15 minutes
Get Live Data
77.30    0.60 (0.78%)
Bid:
77.30
Ask:
77.60
Spread: 0.30 (0.388%)
Market Cap: £371.79m
CHRY Live PriceLast checked at - London Stock Exchange

Intraday Chrysalis Inves Share Chart

Portfolio Update

11 Jul 2022 13:17

RNS Number : 0427S
Chrysalis Investments Limited
11 July 2022
 

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, any member state of the European Economic Area (other than to professional investors in the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa.

 

 

11 July 2022

 

 

Chrysalis Investments Limited ("Chrysalis" or the "Company")

 

Portfolio Update

 

 

Today, the Company can report that Klarna Holding AB ("Klarna") has announced an $800m funding round that values the company at $6.65 billion post new money.

The round, which was larger than anticipated, was led by Sequoia Capital and has been undertaken at a valuation that represents a material discount to the Company's current carrying value of the asset. Other investors in the round include Silver Lake and Commonwealth Bank of Australia, both existing investors, and new investors such as Mubadala Investment Company and the Canadian Pension Plan Investment Board.

The Company's Investment Adviser believes the current valuation to be very attractive, and the Company has therefore committed to its pro-rata entitlement of $8.7 million. Consequently, the Company will not suffer any dilution of its holding because of this funding round.

The Company first invested in Klarna in August 2019 at a post-money valuation of $5.5 billion, with an EV/Sales multiple of approximately 6.7x. In 2019, Klarna generated revenues of $753m and a +20% rate of growth. The company had a very strong market position in the Nordics and Germany but had not fully proven its ability to penetrate some of the largest ecommerce markets globally, including the US, UK and Asia.

Since our initial investment, Klarna has achieved the following milestones:

· Revenues have grown from $753 million in 2019 to $1.6 billion in 2021 (+112%).

· Gross Merchandise Volume (GMV) processed has increased by $45 billion (to $80 billion).

· The number of Global Active Users has increased from 60 million to 150 million (+150%).

· The number of users in the US has increased to 27 million (+700%).

· The number of merchants using Klarna has increased from 130k to 400k (+167%).

· 10 new markets have been entered and Klarna is now present in 45 countries globally.

· The company has acquired Pricerunner, Hero, Inspirock, APPRL and Stocard.

· A global partnership with Stripe was announced in October 2021 giving access to millions more small-to-medium sized businesses.

Over the past three years, Klarna has grown into a global payments business with a dominant market position in several territories. The company's rate of growth has accelerated, and the customer and merchant base has expanded materially. Innovative products and services have continued to be rolled out across new and growing verticals such as travel, event ticketing, beauty, and high-frequency verticals such as pharmacy and grocery.

The current valuation of $6.7 billion implies an EV/Sales multiple of approximately 3.0x; this represents a discount of over 30% to Affirm's EV/Sales multiple and a 55% derating versus our initial entry valuation. Some investors view Affirm as Klarna's closest listed peer.

 

Richard Watts (co-portfolio manager) comments:

''The current funding round does not reflect Klarna's progress since our initial investment, it reflects the very attractive terms that providers of capital are demanding against the current macroeconomic backdrop. We remain extremely positive on the outlook and potential of this business and believe that Klarna now has sufficient capital to reach profitability, whilst continuing to grow strongly.''

 

Company Update

As announced on 23 May 2022, the Company's net asset value ("NAV") per ordinary share was 211.76p as of 31 March 2022.

It is estimated that the revised valuation of the Company's investment in Klarna due to this funding round, along with the movement of listed assets and FX post-period end, would result in a decrease in the NAV per ordinary share of approximately 32p as compared to the Company's last reported NAV per ordinary share. The resulting NAV would therefore be 179.50p

Note that 45% of the portfolio is currently profitable and 51% of the portfolio is now either profitable or has sufficient cash to reach profitability. The remaining 44% of the portfolio, excluding cash, has approximately 15 months of runway without raising further capital.

 

Cash Update

As of 7 July 2022, the Company held approximately £51m of cash. In addition, the Company also has significant further liquidity available, most notably its holdings in listed assets, which currently total approximately £64m.

 

Portfolio Composition

As of 7 July 2022, the portfolio composition was as follows:

 

Portfolio Company 

% of portfolio 

Starling

25.1%

Wefox

13.3%

Smart Pension

10.6%

The Brandtech Group

10.5%

Graphcore

6.1%

Klarna

5.5%

Featurespace

3.8%

Tactus

3.7%

InfoSum

3.3%

Deep Instinct

3.2%

Sorted

2.7%

Wise

2.3%

Revolution Beauty

1.9%

THG

1.7%

Secret Escapes

1.5%

Growth Street

0.0%

Rowanmoor

0.0%

Cash

4.8%

 

Source: Jupiter Investment Management Limited. Holding sizes, as of 7 July 2022, are calculated using 31 March valuations, adjusted for FX as of 7 July 2022 and capturing transactions concluded post the NAV calculation period, and thus using cash as of 7 July. For listed shares, the holding values are based on closing share prices as of 7 July, namely: THG at 82p; Wise at 351p; and Revolution Beauty at 73p. Due to rounding the figures may not add up to 100%. The above percentages are based on an aggregate portfolio value (including cash) of approximately £1.07 billion.

 

-ENDS-

 

 

 

For further information, please contact

 

Media

Montfort Communications

Charlotte McMullen / Georgia Colkin / Lesley Kezhu Wang

 

 

 

 

 

+44 (0) 7542 846 844

chrysalis@montfort.london

Jupiter Asset Management:

James Simpson

 

+44 (0) 20 3817 1696

Liberum:

Chris Clarke / Darren Vickers / Owen Matthews

 

+44 (0) 20 3100 2000

Numis:

Nathan Brown / Matt Goss

 

+44 (0) 20 7260 1000

Maitland Administration (Guernsey) Limited:

Elaine Smeja / Aimee Gontier

+44 (0) 1481 749364

 

LEI: 213800F9SQ753JQHSW24

A copy of this announcement will be available on the Company's website at https://www.chrysalisinvestments.co.uk

The information contained in this announcement regarding the Company's investments has been provided by the relevant underlying portfolio company and has not been independently verified by the Company. The information contained herein is unaudited.

This announcement is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFULFLFFLDLFBBE
Date   Source Headline
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
23rd Feb 20267:00 amRNSTransaction in Own Shares
20th Feb 20262:58 pmRNSBoard clarification in response to stmt by CIP
20th Feb 20267:02 amRNSTransaction in Own Shares
20th Feb 20267:01 amRNSPropose New Inv Policy New Mgmt Arr. Notice of EGM
20th Feb 20267:00 amRNSAppointment of Director
19th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
12th Feb 20267:00 amRNSTransaction in Own Shares
11th Feb 20267:00 amRNSTransaction in Own Shares
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 202612:30 pmRNSHolding(s) in Company
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:01 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSQuarterly NAV Announcement and Trading Update
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSTransaction in Own Shares
13th Jan 20267:00 amRNSTransaction in Own Shares
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20262:43 pmRNSTransaction in Own Shares
31st Dec 20257:01 amRNSDirector Resignation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.